The global Flu Vaccine market is projected to grow from US$ 5791.7 million in 2024 to US$ 7673.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Flu Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

Report Covers:

This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Flu Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Flu Vaccine Market Report

Report Metric	Details
Report Name	Flu Vaccine Market
Accounted market size in 2024	US$ 5791.7 million
Forecasted market size in 2030	US$ 7673.2 million
CAGR	4.8
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	For Children (6 months to 3 years) For Adults and Children over 3 years
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Flu Vaccine Market growing?

Ans: The Flu Vaccine Market witnessing a CAGR of 4.8 during the forecast period 2024-2030.

What is the Flu Vaccine Market size in 2030?

Ans: The Flu Vaccine Market size in 2030 will be US$ 7673.2 million.

What is the market share of major companies in Flu Vaccine Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Flu Vaccine Market share by type?

Ans: In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%.

Who are the main players in the Flu Vaccine Market report?

Ans: The main players in the Flu Vaccine Market are GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO

What are the Application segmentation covered in the Flu Vaccine Market report?

Ans: The Applications covered in the Flu Vaccine Market report are For Children (6 months to 3 years), For Adults and Children over 3 years

What are the Type segmentation covered in the Flu Vaccine Market report?

Ans: The Types covered in the Flu Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Study Coverage

1.1 Flu Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Flu Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Market by Application

1.3.1 Global Flu Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Flu Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Flu Vaccine Revenue by Region

2.2.1 Global Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Flu Vaccine Revenue by Region (2019-2024)

2.2.3 Global Flu Vaccine Revenue by Region (2025-2030)

2.2.4 Global Flu Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Flu Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Flu Vaccine Sales by Region

2.4.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Flu Vaccine Sales by Region (2019-2024)

2.4.3 Global Flu Vaccine Sales by Region (2025-2030)

2.4.4 Global Flu Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Flu Vaccine Sales by Manufacturers

3.1.1 Global Flu Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Flu Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Flu Vaccine in 2023

3.2 Global Flu Vaccine Revenue by Manufacturers

3.2.1 Global Flu Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Flu Vaccine Revenue in 2023

3.3 Global Key Players of Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Flu Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Flu Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Flu Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Flu Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Flu Vaccine Sales by Type

4.1.1 Global Flu Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Flu Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Flu Vaccine Revenue by Type

4.2.1 Global Flu Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Flu Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Flu Vaccine Price by Type

4.3.1 Global Flu Vaccine Price by Type (2019-2024)

4.3.2 Global Flu Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Flu Vaccine Sales by Application

5.1.1 Global Flu Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Flu Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Flu Vaccine Revenue by Application

5.2.1 Global Flu Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Flu Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Flu Vaccine Price by Application

5.3.1 Global Flu Vaccine Price by Application (2019-2024)

5.3.2 Global Flu Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Flu Vaccine Market Size by Type

6.1.1 US & Canada Flu Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Flu Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Flu Vaccine Market Size by Application

6.2.1 US & Canada Flu Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Flu Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Flu Vaccine Market Size by Country

6.3.1 US & Canada Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Flu Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Flu Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Flu Vaccine Market Size by Type

7.1.1 Europe Flu Vaccine Sales by Type (2019-2030)

7.1.2 Europe Flu Vaccine Revenue by Type (2019-2030)

7.2 Europe Flu Vaccine Market Size by Application

7.2.1 Europe Flu Vaccine Sales by Application (2019-2030)

7.2.2 Europe Flu Vaccine Revenue by Application (2019-2030)

7.3 Europe Flu Vaccine Market Size by Country

7.3.1 Europe Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Flu Vaccine Sales by Country (2019-2030)

7.3.3 Europe Flu Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Flu Vaccine Market Size

8.1.1 China Flu Vaccine Sales (2019-2030)

8.1.2 China Flu Vaccine Revenue (2019-2030)

8.2 China Flu Vaccine Market Size by Application

8.2.1 China Flu Vaccine Sales by Application (2019-2030)

8.2.2 China Flu Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Flu Vaccine Market Size by Type

9.1.1 Asia Flu Vaccine Sales by Type (2019-2030)

9.1.2 Asia Flu Vaccine Revenue by Type (2019-2030)

9.2 Asia Flu Vaccine Market Size by Application

9.2.1 Asia Flu Vaccine Sales by Application (2019-2030)

9.2.2 Asia Flu Vaccine Revenue by Application (2019-2030)

9.3 Asia Flu Vaccine Sales by Region

9.3.1 Asia Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Flu Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Flu Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Flu Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Flu Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Flu Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Flu Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Flu Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Flu Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Flu Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Flu Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Flu Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sanofi Pasteur

11.1.1 Sanofi Pasteur Company Information

11.1.2 Sanofi Pasteur Overview

11.1.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sanofi Pasteur Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Pasteur Recent Developments

11.2 CSL

11.2.1 CSL Company Information

11.2.2 CSL Overview

11.2.3 CSL Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 CSL Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 CSL Recent Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Overview

11.3.3 GSK Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 GSK Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GSK Recent Developments

11.4 Mylan

11.4.1 Mylan Company Information

11.4.2 Mylan Overview

11.4.3 Mylan Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Mylan Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Mylan Recent Developments

11.5 Hulan Bio

11.5.1 Hulan Bio Company Information

11.5.2 Hulan Bio Overview

11.5.3 Hulan Bio Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Hulan Bio Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Hulan Bio Recent Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Information

11.6.2 AstraZeneca Overview

11.6.3 AstraZeneca Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 AstraZeneca Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 AstraZeneca Recent Developments

11.7 CCBIO

11.7.1 CCBIO Company Information

11.7.2 CCBIO Overview

11.7.3 CCBIO Flu Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 CCBIO Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 CCBIO Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Flu Vaccine Industry Chain Analysis

12.2 Flu Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Flu Vaccine Production Mode & Process

12.4 Flu Vaccine Sales and Marketing

12.4.1 Flu Vaccine Sales Channels

12.4.2 Flu Vaccine Distributors

12.5 Flu Vaccine Customers

13 Market Dynamics

13.1 Flu Vaccine Industry Trends

13.2 Flu Vaccine Market Drivers

13.3 Flu Vaccine Market Challenges

13.4 Flu Vaccine Market Restraints

14 Key Findings in The Global Flu Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Flu Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Trivalent Influenza Vaccine

Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine

Table 4. Global Flu Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Flu Vaccine Revenue Market Share by Region (2019-2024)

Table 9. Global Flu Vaccine Revenue Market Share by Region (2025-2030)

Table 10. Global Flu Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Flu Vaccine Sales by Region (2019-2024) & (M Doses)

Table 12. Global Flu Vaccine Sales by Region (2025-2030) & (M Doses)

Table 13. Global Flu Vaccine Sales Market Share by Region (2019-2024)

Table 14. Global Flu Vaccine Sales Market Share by Region (2025-2030)

Table 15. Global Flu Vaccine Sales by Manufacturers (2019-2024) & (M Doses)

Table 16. Global Flu Vaccine Sales Share by Manufacturers (2019-2024)

Table 17. Global Flu Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Flu Vaccine Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Flu Vaccine Price by Manufacturers 2019-2024 (US$/Dose)

Table 21. Global Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccine as of 2023)

Table 23. Global Key Manufacturers of Flu Vaccine, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Flu Vaccine, Product Offered and Application

Table 25. Global Key Manufacturers of Flu Vaccine, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 28. Global Flu Vaccine Sales by Type (2025-2030) & (M Doses)

Table 29. Global Flu Vaccine Sales Share by Type (2019-2024)

Table 30. Global Flu Vaccine Sales Share by Type (2025-2030)

Table 31. Global Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Flu Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Flu Vaccine Revenue Share by Type (2019-2024)

Table 34. Global Flu Vaccine Revenue Share by Type (2025-2030)

Table 35. Flu Vaccine Price by Type (2019-2024) & (US$/Dose)

Table 36. Global Flu Vaccine Price Forecast by Type (2025-2030) & (US$/Dose)

Table 37. Global Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 38. Global Flu Vaccine Sales by Application (2025-2030) & (M Doses)

Table 39. Global Flu Vaccine Sales Share by Application (2019-2024)

Table 40. Global Flu Vaccine Sales Share by Application (2025-2030)

Table 41. Global Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Flu Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Flu Vaccine Revenue Share by Application (2019-2024)

Table 44. Global Flu Vaccine Revenue Share by Application (2025-2030)

Table 45. Flu Vaccine Price by Application (2019-2024) & (US$/Dose)

Table 46. Global Flu Vaccine Price Forecast by Application (2025-2030) & (US$/Dose)

Table 47. US & Canada Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 48. US & Canada Flu Vaccine Sales by Type (2025-2030) & (M Doses)

Table 49. US & Canada Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Flu Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 52. US & Canada Flu Vaccine Sales by Application (2025-2030) & (M Doses)

Table 53. US & Canada Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Flu Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 59. US & Canada Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 60. Europe Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 61. Europe Flu Vaccine Sales by Type (2025-2030) & (M Doses)

Table 62. Europe Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Flu Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 65. Europe Flu Vaccine Sales by Application (2025-2030) & (M Doses)

Table 66. Europe Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Flu Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 72. Europe Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 73. China Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 74. China Flu Vaccine Sales by Type (2025-2030) & (M Doses)

Table 75. China Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Flu Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 78. China Flu Vaccine Sales by Application (2025-2030) & (M Doses)

Table 79. China Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Flu Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 82. Asia Flu Vaccine Sales by Type (2025-2030) & (M Doses)

Table 83. Asia Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Flu Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 86. Asia Flu Vaccine Sales by Application (2025-2030) & (M Doses)

Table 87. Asia Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Flu Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Flu Vaccine Sales by Region (2019-2024) & (M Doses)

Table 93. Asia Flu Vaccine Sales by Region (2025-2030) & (M Doses)

Table 94. Middle East, Africa and Latin America Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 95. Middle East, Africa and Latin America Flu Vaccine Sales by Type (2025-2030) & (M Doses)

Table 96. Middle East, Africa and Latin America Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Flu Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 99. Middle East, Africa and Latin America Flu Vaccine Sales by Application (2025-2030) & (M Doses)

Table 100. Middle East, Africa and Latin America Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Flu Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 106. Middle East, Africa and Latin America Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 107. Sanofi Pasteur Company Information

Table 108. Sanofi Pasteur Description and Major Businesses

Table 109. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 110. Sanofi Pasteur Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Sanofi Pasteur Recent Developments

Table 112. CSL Company Information

Table 113. CSL Description and Major Businesses

Table 114. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 115. CSL Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. CSL Recent Developments

Table 117. GSK Company Information

Table 118. GSK Description and Major Businesses

Table 119. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 120. GSK Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. GSK Recent Developments

Table 122. Mylan Company Information

Table 123. Mylan Description and Major Businesses

Table 124. Mylan Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 125. Mylan Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Mylan Recent Developments

Table 127. Hulan Bio Company Information

Table 128. Hulan Bio Description and Major Businesses

Table 129. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 130. Hulan Bio Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Hulan Bio Recent Developments

Table 132. AstraZeneca Company Information

Table 133. AstraZeneca Description and Major Businesses

Table 134. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 135. AstraZeneca Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. AstraZeneca Recent Developments

Table 137. CCBIO Company Information

Table 138. CCBIO Description and Major Businesses

Table 139. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 140. CCBIO Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. CCBIO Recent Developments

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Flu Vaccine Distributors List

Table 145. Flu Vaccine Customers List

Table 146. Flu Vaccine Market Trends

Table 147. Flu Vaccine Market Drivers

Table 148. Flu Vaccine Market Challenges

Table 149. Flu Vaccine Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Flu Vaccine Product Picture

Figure 2. Global Flu Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Flu Vaccine Market Share by Type in 2023 & 2030

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Flu Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Flu Vaccine Market Share by Application in 2023 & 2030

Figure 8. For Children (6 months to 3 years)

Figure 9. For Adults and Children over 3 years

Figure 10. Flu Vaccine Report Years Considered

Figure 11. Global Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Flu Vaccine Revenue 2019-2030 (US$ Million)

Figure 13. Global Flu Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Flu Vaccine Revenue Market Share by Region (2019-2030)

Figure 15. Global Flu Vaccine Sales 2019-2030 ((M Doses)

Figure 16. Global Flu Vaccine Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Flu Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 18. US & Canada Flu Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Flu Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 20. Europe Flu Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Flu Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 22. China Flu Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Flu Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 24. Asia (excluding China) Flu Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Flu Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 26. Middle East, Africa and Latin America Flu Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Flu Vaccine in the World: Market Share by Flu Vaccine Revenue in 2023

Figure 29. Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Flu Vaccine Sales Market Share by Type (2019-2030)

Figure 31. Global Flu Vaccine Revenue Market Share by Type (2019-2030)

Figure 32. Global Flu Vaccine Sales Market Share by Application (2019-2030)

Figure 33. Global Flu Vaccine Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Flu Vaccine Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Flu Vaccine Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Flu Vaccine Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Flu Vaccine Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Flu Vaccine Revenue Share by Country (2019-2030)

Figure 39. US & Canada Flu Vaccine Sales Share by Country (2019-2030)

Figure 40. U.S. Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Flu Vaccine Sales Market Share by Type (2019-2030)

Figure 43. Europe Flu Vaccine Revenue Market Share by Type (2019-2030)

Figure 44. Europe Flu Vaccine Sales Market Share by Application (2019-2030)

Figure 45. Europe Flu Vaccine Revenue Market Share by Application (2019-2030)

Figure 46. Europe Flu Vaccine Revenue Share by Country (2019-2030)

Figure 47. Europe Flu Vaccine Sales Share by Country (2019-2030)

Figure 48. Germany Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 49. France Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. China Flu Vaccine Sales Market Share by Type (2019-2030)

Figure 54. China Flu Vaccine Revenue Market Share by Type (2019-2030)

Figure 55. China Flu Vaccine Sales Market Share by Application (2019-2030)

Figure 56. China Flu Vaccine Revenue Market Share by Application (2019-2030)

Figure 57. Asia Flu Vaccine Sales Market Share by Type (2019-2030)

Figure 58. Asia Flu Vaccine Revenue Market Share by Type (2019-2030)

Figure 59. Asia Flu Vaccine Sales Market Share by Application (2019-2030)

Figure 60. Asia Flu Vaccine Revenue Market Share by Application (2019-2030)

Figure 61. Asia Flu Vaccine Revenue Share by Region (2019-2030)

Figure 62. Asia Flu Vaccine Sales Share by Region (2019-2030)

Figure 63. Japan Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. India Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Flu Vaccine Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Flu Vaccine Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Flu Vaccine Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Flu Vaccine Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Flu Vaccine Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Flu Vaccine Sales Share by Country (2019-2030)

Figure 74. Brazil Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Flu Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Flu Vaccine Value Chain

Figure 80. Flu Vaccine Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions